Navigation Links
PDI, Inc. to Hold First Quarter 2012 Financial Results Conference Call on Tuesday, May 15, 2012
Date:5/8/2012

PARSIPPANY, N.J., May 8, 2012 /PRNewswire/ -- PDI, Inc. (Nasdaq: PDII) today announced that it will release its first quarter 2012 financial results on Monday, May 14, 2012 after the market close and host a conference call on Tuesday, May 15, at 8:30 am Eastern time to discuss the results.Access information:Date:

Tuesday, May 15, 2012Time: 

8:30 am Eastern timeDial-in numbers: 

(866) 644-4654 (U.S. and Canada) or (706) 643-1203Conference ID number:

72367450Live web cast: 

www.pdi-inc.com, under "Investor Relations"The teleconference replay will be available three hours after completion through May 19, 2012 at (800) 585-8367 (U.S. and Canada) or (404) 537-3406. The replay pass code is 72367450. The archived web cast will be available for one year on the company's web site, www.pdi-inc.com, under "Investor Relations."

About PDI, Inc.
PDI is a leading health care commercialization company providing superior insight-driven, integrated multi-channel message delivery to established and emerging health care companies. The company is dedicated to enhancing engagement with health care practitioners and optimizing commercial investments for its clients by providing strategic flexibility, full product commercialization services, innovative multi-channel promotional solutions, and sales and marketing expertise. For more information, please visit the company's website at http://www.pdi-inc.com.


'/>"/>
SOURCE PDI, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Sinovac to Host Conference Call to Report First Quarter 2012 Unaudited Financial Results
2. AcelRx Pharmaceuticals Reports First Quarter 2012 Financial Results
3. Par Pharmaceutical Companies Reports First Quarter 2012 Results
4. InspireMD Announces First Quarter 2012 Financial Results
5. Stereotaxis Reports Improved First Quarter 2012 Financial Results
6. Henry Schein Reports Record First Quarter Results
7. Isis Reports Financial Results and Highlights for First Quarter 2012
8. Insmed Announces First Quarter 2012 Financial Results
9. Vanda Pharmaceuticals Reports First Quarter 2012 Results
10. Mindray Announces First Quarter 2012 Financial Results
11. Halozyme Reports First Quarter 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... , April 20, 2017 NeuroVive Pharmaceutical ... today announced positive preclinical results demonstrating anti-fibrotic ... for non-alcoholic steatohepatitis (NASH), in an additional ... NV556 has previously shown similar anti-fibrotic ... Today, NeuroVive,s scientists present novel data demonstrating ...
(Date:4/19/2017)... 2017  IRIDEX Corporation (Nasdaq: IRIX ) ... the first quarter 2017 after the close of trading ... will host a corresponding conference call beginning at 2:30 ... interested in listening to the conference call may do ... (703) 326-3030 for international callers, using conference ID: 92158987.  ...
(Date:4/19/2017)... April 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... biopharmaceutical company developing new treatments for cancer and ... of its previously announced underwritten public offering of ... public offering price of $2.00 per share, before ... expenses payable by Sorrento.  The net proceeds to ...
Breaking Medicine Technology:
(Date:4/25/2017)... ... April 25, 2017 , ... ... modern procedure that achieves results in a fraction of the time as traditional ... NV, with Significance Dental Specialists, now offers this revolutionary treatment with or without ...
(Date:4/25/2017)... ... April 25, 2017 , ... Back Pain Centers of America ... with a reputable physician in their area, announces the launch of a new and ... patients who are looking for reputable physicians to help them with back or neck ...
(Date:4/25/2017)... ... April 25, 2017 , ... Somnoware, a ... its patient care management module. Using this new feature, sleep physicians can now ... initiated on continuous positive airway pressure (CPAP), oral, or other forms of sleep ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... products, is introducing Flexadin UCII, part of the EQUISTRO line, at this week’s ... health in horses at the immunologic level. , The scientifically-developed Flexadin UCII supports ...
(Date:4/24/2017)... ... April 24, 2017 , ... LG CNS Healthcare Solutions ... (BYOD) capabilities at Telehealth 2.0, the American Telemedicine Association’s national conference. , BYOD ... devices with a pre-programmed tablet in a remarkably easy-to-use kit for patients. “BYOD ...
Breaking Medicine News(10 mins):